Precision medicine’s chicken and egg problem


After 15 years of completing the human genome project, the progress of precision medicine appears to be very slow. Some believe it is due to precision medicine and companion diagnostics have a chicken and egg problem. Drug companies that would be developing a companion diagnostic need to understand the molecular basis of the disease in order to test something. They often have to develop something in parallel using diagnostics development and assay development testing in the entire diagnostics realm of the world. However, they usually hesitate to invest in that before they know they have efficacy or signs of efficacy in the drug being developed. When precision medicine is promising and exciting, to actually move to healthcare delivery, it has to demonstrate scale, which so far it has not yet.


RECENT POSTS

FEATURED POSTS

FOLLOW US

  • Grey Facebook Icon
  • Grey Twitter Icon
  • Grey Instagram Icon
  • Grey Google+ Icon
  • Grey Pinterest Icon

ABOUT Cooldo

Our management consulting service focus on disease prevention, extending human healthspan, and total wellbeing. 

 

We assist healthcare providers, caregivers, and health promotion organizations in designing and developing the most cost-effective ways to improve their process and service delivery. We help our customers to identify the top products on the market and the best way to utilize them to reach their business and organizational goals. We help solution providers to enhance their products and package the right solutions to the market. 

 

With competencies in healthcare and technology, we are here to find the best solutions for health promotion and disease prevention. 

© 2017 - 2021 by Cooldo